GlassScriptPhysician profile
Katherine Grimsley
NPI 1407880446
$1,033.78
in general payments reported to CMS, 2019-2025
17 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $610 · 2020: $87.53 · 2021: $118 · 2022: $21.50 · 2023: $18.34 · 2024: $65.63 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $196.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $205.84 | 2019-2025 | Invega Sustenna |
| Sunovion Pharmaceuticals INC. | $157.98 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $120.95 | 2019-2025 | Austedo Xr |
| Lundbeck LLC | $90.78 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $64.67 | 2019 | |
| Merck Sharp & Dohme LLC | $52.27 | 2019-2021 | |
| Abbvie INC. | $48.33 | 2023-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $46.91 | 2021 | |
| Allergan, INC. | $39.42 | 2019 | |
| Alkermes, INC. | $36.50 | 2019 | |
| Axsome Therapeutics, INC. | $35.80 | 2024-2025 | Auvelity |
| E.R. Squibb & Sons, L.L.C. | $35.64 | 2024-2025 | Cobenfy |
| Vanda Pharmaceuticals INC. | $31.65 | 2021-2025 | Fanapt |
| Indivior INC. | $21.50 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.05 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $15.17 | 2019 | |
| Neurocrine Biosciences, INC. | $12.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Grimsley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.